MediFind found 306 doctor with experience in Non-Small Cell Lung Cancer (NSCLC) near Concord, MA. Of these, 222 are Experienced, 53 are Advanced, 16 are Distinguished and 15 are Elite.
The General Hospital Corporation
Lecia Sequist is an Oncologist and a Hematologist in Waltham, Massachusetts. Dr. Sequist is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy. Dr. Sequist is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Biagio Ricciuti is an Oncologist in Boston, Massachusetts. Dr. Ricciuti is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Metastatic Pleural Tumor.
Leena Gandhi is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Gandhi is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Thymic Epithelial Tumor.
Are you looking for a specific type of Non-Small Cell Lung Cancer (NSCLC)?
Common conditions include: EGFR Positive Lung Cancer, Large-Cell Lung Carcinoma, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma
Dana-Farber Cancer Institute, Inc.
David Jackman is an Oncologist in Chestnut Hill, Massachusetts. Dr. Jackman is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Mesothelioma. Dr. Jackman is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Alice Shaw is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Shaw is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Shaw is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Pasi Janne is an Oncologist in Boston, Massachusetts. Dr. Janne is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lung Cancer, Lung Adenocarcinoma, and Tissue Biopsy. Dr. Janne is currently accepting new patients.
Bruce Johnson is an Oncologist in Boston, Massachusetts. Dr. Johnson is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and EGFR Positive Lung Cancer. Dr. Johnson is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Raymond Mak is a Radiation Oncologist in Boston, Massachusetts. Dr. Mak is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Mak is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Jacob Sands is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Sands is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Sands is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
David Kozono is a Radiation Oncologist in Boston, Massachusetts. Dr. Kozono is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Dana-Farber Cancer Institute, Inc.
Julia Rotow is an Oncologist in Boston, Massachusetts. Dr. Rotow is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Lung Adenocarcinoma. Dr. Rotow is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Michael Rabin is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Rabin is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Rabin is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
David Kwiatkowski is an Oncologist in Boston, Massachusetts. Dr. Kwiatkowski has been practicing medicine for over 46 years and is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Adenocarcinoma, Lung Cancer, Mesothelioma, and Non-Small Cell Lung Cancer (NSCLC).
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc
Daniel Costa is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Costa is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Costa is currently accepting new patients.
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc
Deepa Rangachari is an Oncologist in Boston, Massachusetts. Dr. Rangachari is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Thymectomy. Dr. Rangachari is currently accepting new patients.
Lahey Clinic Inc
Paul Hesketh is a Hematologist Oncology specialist and an Oncologist in Burlington, Massachusetts. Dr. Hesketh is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Hesketh is currently accepting new patients.
Radiation Oncology Associates, PA
Asa Nixon is a Radiation Oncologist in Burlington, Massachusetts. Dr. Nixon is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Nixon is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Narjust Florez is an Oncologist in Boston, Massachusetts. Dr. Florez has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and EGFR Positive Lung Cancer. Dr. Florez is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Meredith Faggen is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Faggen is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Faggen is currently accepting new patients.
Kimberly Brennan is an Oncologist in Concord, Massachusetts. Dr. Brennan is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), Inflammatory Breast Cancer, and Non-Hodgkin Lymphoma.
Last Updated: 10/30/2025

